A prediction model integrated genomic alterations and immune signatures of tumor immune microenvironment for early recurrence of stage I NSCLC after curative resection

BACKGROUND: Surgery is the standard treatment for patients with stage I non-small cell lung cancer (NSCLC). However, postoperative recurrence leads to a poor prognosis of patients. Currently, there is no effective prognostic biomarker and perioperative treatment for patients with stage I NSCLC. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Chunhong, Shu, Long, Chen, Chen, Fan, Songqing, Liang, Qingchun, Zheng, Hongmei, Pan, Yue, Zhao, Lishu, Zou, Fangwen, Liu, Chaoyuan, Liu, Wenliang, Yu, Feng-Lei, Liu, Xianling, Liu, Lijuan, Yang, Lingling, Shao, Yang, Wu, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825654/
https://www.ncbi.nlm.nih.gov/pubmed/35242625
http://dx.doi.org/10.21037/tlcr-21-751

Ejemplares similares

Ejemplares similares